COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Phase II Study of BVD-523 in Metastatic Uveal Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03417739
Recruitment Status : Active, not recruiting
First Posted : January 31, 2018
Last Update Posted : June 16, 2020
BioMed Valley Discoveries, Inc
Information provided by (Responsible Party):
Elizabeth Buchbinder, Dana-Farber Cancer Institute

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : May 11, 2020
Estimated Study Completion Date : August 31, 2025